Abstract

Diabetic animal models have made significant contributions to understanding the etiology of diabetes and to the development of new medications. Our research group recently developed a novel diabetic mouse strain, the insulin hyposecretion (ihs)mouse. The strain involves neither obesity nor insulitis but exhibits notable pancreatic β-cell dysfunction, distinguishing it from other well-characterized animal models. In ihs mice, severe impairment of insulin secretion from pancreas has been elicited by glucose or potassium chloride stimulation. To clarify the genetic basis of impaired insulin secretion, beginning with identifying the causative gene, genetic linkage analysis was performed using [(C57BL/6 × ihs) F1 × ihs] backcross progeny. Genetic linkage analysis and quantitative trait loci analysis for blood glucose after oral glucose loading indicated that a recessively acting locus responsible for impaired glucose tolerance was mapped to a 14.9-Mb region of chromosome 18 between D18Mit233 and D18Mit235 (the ihs locus). To confirm the gene responsible for the ihs locus, a congenic strain harboring the ihs locus on the C57BL/6 genetic background was developed. Phenotypic analysis of B6.ihs-(D18Mit233-D18Mit235) mice showed significant glucose tolerance impairment and markedly lower plasma insulin levels during an oral glucose tolerance test. Whole-genome sequencing and Sanger sequencing analyses on the ihs genome detected two ihs-specific variants changing amino acids within the ihs locus; both variants in Slc25a46 and Tcerg1 were predicted to disrupt the protein function. Based on information regarding gene functions involving diabetes mellitus and insulin secretion, reverse-transcription quantitative polymerase chain reaction analysis revealed that the relative abundance of Reep2 and Sil1 transcripts from ihs islets was significantly decreased whereas that of Syt4 transcripts were significantly increased compared with those of control C57BL/6 mice. Thus, Slc25a46, Tcerg1, Syt4, Reep2 and Sil1 are potential candidate genes for the ihs locus. This will be the focus of future studies in both mice and humans.

Highlights

  • Type 2 diabetes (T2D) is a metabolic disorder characterized by abnormal glucose homeostasis due to a defect in the secretion and/or action of insulin

  • Our research group demonstrated that ihs mice showed marked impaired glucose tolerance due to impaired insulin secretion [9]

  • Based on the result of oral glucose tolerance test (OGTT) in B6, ihs and F1 mice (Fig 1A), we divided them into two groups (NGT and impaired glucose tolerance (IGT) type) at 250 mg/dl (Fig 1C)

Read more

Summary

Introduction

Type 2 diabetes (T2D) is a metabolic disorder characterized by abnormal glucose homeostasis due to a defect in the secretion and/or action of insulin. T2D in East Asian countries is characterized by lower levels of insulin secretion from pancreatic islets and more frequently a non-obese type, differing from its pattern among Caucasians [2,3,4,5]. The etiology of T2D is complicated, involving multiple genetic and environmental factors [6]. There has been increased interest in animal models of T2D which genetic and environmental factors that could influence the development of the disease and related complications can be precisely controlled in vivo. Animal models have made significant contributions to the study of diabetes mellitus, providing new information on its management and treatment in humans [7, 8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call